نتایج جستجو برای: eluting stents outcome assessment

تعداد نتایج: 903119  

Journal: :Journal of the American College of Cardiology 2010
Lorenz Räber Peter Jüni Lukas Löffel Simon Wandel Stéphane Cook Peter Wenaweser Mario Togni Rolf Vogel Christian Seiler Franz Eberli Thomas Lüscher Bernhard Meier Stephan Windecker

OBJECTIVES We compared the angiographic and long-term clinical outcomes of patients with and without overlap of drug-eluting stents (DES). BACKGROUND DES overlap has been associated with delayed healing and increased inflammation in experimental studies, but its impact on clinical outcome is not well established. METHODS We analyzed the angiographic and clinical outcomes of 1,012 patients t...

Journal: :Circulation 2018
Ziad A Ali Runlin Gao Takeshi Kimura Yoshinobu Onuma Dean J Kereiakes Stephen G Ellis Bernard Chevalier Minh-Thien Vu Zhen Zhang Charles A Simonton Patrick W Serruys Gregg W Stone

BACKGROUND The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3 years after coronary artery implantation. The safety and effectiveness of BVS through this critical 3-year period have not been characterized. METHODS We performed an individual-patient-data pooled meta-analysis of the 4 randomized ABSORB trials in which 3389 patients with coronary artery disease were rand...

Journal: :Acta biomaterialia 2015
Sean McGinty Tuoi T N Vo Martin Meere Sean McKee Christopher McCormick

In this paper we provide the first model of drug elution from polymer-free arterial drug-eluting stents. The generalised model is capable of predicting drug release from a number of polymer-free systems including those that exhibit nanoporous, nanotubular and smooth surfaces. We derive analytical solutions which allow us to easily determine the important parameters that control drug release. Dr...

2014
Hiroshi Fujita Kenya Nasu Mitsuyasu Terashima Tsuyoshi Ito Tomomitsu Tani Takahiko Suzuki Nobuyuki Ohte

BACKGROUND Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited. AIM We investigated the efficiency of drug-eluting stents for coronary artery disease in patients on dialysis from the viewpoint of stent sizing. METHODS Sirolimus-eluting stents were implanted in 88 lesions a...

2012
Duminda N. Wijeysundera Harindra C. Wijeysundera Lingsong Yun

Background—Guidelines recommend that noncardiac surgery be delayed until 30 to 45 days after bare-metal stent implantation and 1 year after drug-eluting stent implantation. Methods and Results—We used linked registry data and population-based administrative health care databases to conduct a cohort study of 8116 patients (Ն40 years of age) who underwent major elective noncardiac surgery in Onta...

2011
Dominic J Allocco Anita A Joshi Keith D Dawkins

Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide. This review describes and analyzes the clinical data supporting the use of EES, focusing primarily on published, randomized, controlled trials. Everolimus-eluting stents have been shown to have less restenosis, stent thrombosis, and periprocedural myocardial infarction compared with earlier genera...

2014
Denise Oliveira Pellegrini Vitor Osório Gomes Ricardo Lasevitch Luis Smidt Marco Aurélio Azeredo Priscila Ledur Rodrigo Bodanese Leonardo Sinnott Emílio Moriguchi Paulo Caramori

BACKGROUND Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, particularly if the risks of this event were sustained. In this context, a registry of clinical cases...

Journal: :Circulation 2012
Duminda N Wijeysundera Harindra C Wijeysundera Lingsong Yun Marcin Wąsowicz W Scott Beattie James L Velianou Dennis T Ko

BACKGROUND Guidelines recommend that noncardiac surgery be delayed until 30 to 45 days after bare-metal stent implantation and 1 year after drug-eluting stent implantation. METHODS AND RESULTS We used linked registry data and population-based administrative health care databases to conduct a cohort study of 8116 patients (≥40 years of age) who underwent major elective noncardiac surgery in On...

Journal: :JACC. Cardiovascular interventions 2016
Sebastian Kufner Jonas Sorges Julinda Mehilli Salvatore Cassese Janika Repp Jens Wiebe Raphaela Lohaus Annalena Lahmann Tobias Rheude Tareq Ibrahim Steffen Massberg Karl L Laugwitz Adnan Kastrati Robert A Byrne

OBJECTIVES The aim of this study was to evaluate the late clinical performance of a polymer-free sirolimus- and probucol-eluting stent compared with a new-generation durable polymer-based zotarolimus-eluting stent. BACKGROUND It was previously shown that polymer-free sirolimus- and probucol-eluting stents were noninferior to zotarolimus-eluting stents at 12 months. However, long-term follow-u...

Journal: :BMJ : British Medical Journal 2008
Christoph Stettler Sabin Allemann Simon Wandel Adnan Kastrati Marie Claude Morice Albert Schömig Matthias E Pfisterer Gregg W Stone Martin B Leon José Suárez de Lezo Jean-Jacques Goy Seung-Jung Park Manel Sabaté Maarten J Suttorp Henning Kelbaek Christian Spaulding Maurizio Menichelli Paul Vermeersch Maurits T Dirksen Pavel Cervinka Marco De Carlo Andrejs Erglis Tania Chechi Paolo Ortolani Martin J Schalij Peter Diem Bernhard Meier Stephan Windecker Peter Jüni

OBJECTIVE To compare the effectiveness and safety of three types of stents (sirolimus eluting, paclitaxel eluting, and bare metal) in people with and without diabetes mellitus. DESIGN Collaborative network meta-analysis. DATA SOURCES Electronic databases (Medline, Embase, the Cochrane Central Register of Controlled Trials), relevant websites, reference lists, conference abstracts, reviews, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید